Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jacopo Fontana"'
Autor:
Joachim Koch, Sheena Pinto, Susanne Wingert, Jens Pahl, Chiara Zambarda, Karolin Guldevall, Christian Breunig, Damien Toullec, Jacopo Fontana, Björn Önfelt
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/dde28aa9a42d4f86ae8c60c460702adf
Autor:
Valentina Carannante, Niklas Sandström, Karl Olofsson, Shi Yong Neo, Patrick Albert Sandoz, Hanna Van Ooijen, Quentin Verron, Jacopo Fontana, Damien Toullec, Elisabeth Moussaud-Lamodière, Brinton Seashore-Ludlow, Thomas Frisk, Madoka Takai, Päivi Östling, Felix Haglund, Andreas Lundqvist, Martin Wiklund, Björn Önfelt
Publikováno v:
Cancer Research. 83:4578-4578
Tumor diversity and rarity of patient tumor material negatively contribute to the development of new effective treatments for sarcomas. As a high proportion of sarcoma patients presents inherent or acquired chemo-resistance, immune checkpoint inhibit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf1108aca84b3b5890cf391b0cb14612
https://doi.org/10.1158/1538-7445.am2023-4578
https://doi.org/10.1158/1538-7445.am2023-4578
Autor:
Chiara Zambarda, Karolin Guldevall, Damien Toullec, Susanne Wingert, Christian Breunig, Sheena Pinto, Jacopo Fontana, Joachim Koch, Björn Önfelt
Publikováno v:
Cancer Research. 83:2950-2950
Antibody-Dependent Cellular Cytotoxicity (ADCC) is a powerful mechanism of Natural Killer (NK) cells to kill antibody-opsonized target cells. However, ADCC mediated by conventional antibodies has its limitations in killing of tumor cells commonly bei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a5c967aa78638a79869ea249df06bc03
https://doi.org/10.1158/1538-7445.am2023-2950
https://doi.org/10.1158/1538-7445.am2023-2950
Publikováno v:
Archives of Physical Medicine and Rehabilitation. 103:e157
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dbfa2a62a1f76864354e316198415628
https://doi.org/10.1016/j.apmr.2022.08.854
https://doi.org/10.1016/j.apmr.2022.08.854
Autor:
Chiara Zambarda, Karolin Guldevall, Christian Breunig, Damien Toullec, Jacopo Fontana, Sheena Pinto, Jens Pahl, Susanne Wingert, Joachim Koch, Björn Önfelt
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundThe use of bispecific natural killer (NK) cell engagers has emerged as a successful strategy for immune cell activation and killing of tumor cells through antibody-dependent cellular cytotoxicity (ADCC). Among these, tetravalent, bispecific
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50b100f0a38751dbd8cb307946ee8d85
https://doaj.org/article/dde28aa9a42d4f86ae8c60c460702adf
https://doaj.org/article/dde28aa9a42d4f86ae8c60c460702adf
Autor:
Yuly Sánchez-Hernández, Umberto Laforenza, Elisa Bonetti, Jacopo Fontana, Silvia Dragoni, Marika Russo, José Everardo Avelino-Cruz, Sergio Schinelli, Domenico Testa, Germano Guerra, Vittorio Rosti, Franco Tanzi, Francesco Moccia
Publikováno v:
Stem Cells & Development; Dec2010, Vol. 19 Issue 12, p1967-1981, 15p